Shi-Bing Wang Selected Research

Shi-Bing Wang Research Topics

Disease

23	Neoplasms (Cancer) 02/2021 - 02/2012
3	Hepatocellular Carcinoma (Hepatoma) 01/2018 - 02/2012
2	Triple Negative Breast Neoplasms 08/2020 - 09/2017
2	Carcinoma (Carcinomatosis) 01/2018 - 02/2012
2	Colorectal Neoplasms (Colorectal Cancer) 09/2016 - 01/2016
1	Circulating Neoplastic Cells 12/2019
1	Glioblastoma (Glioblastoma Multiforme) 10/2019
1	Melanoma (Melanoma, Malignant) 01/2019
1	Inflammation (Inflammations) 12/2018
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2018
1	Neoplasm Metastasis (Metastasis) 01/2016
1	Breast Neoplasms (Breast Cancer) 02/2015
1	MELAS Syndrome (Syndrome, MELAS) 08/2008
1	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 08/2008
1	Stroke (Strokes) 08/2008
1	Lactic Acidosis 08/2008
1	Mitochondrial encephalopathy 08/2008
1	Status Epilepticus (Complex Partial Status Epilepticus) 08/2008
1	Wolff-Parkinson-White Syndrome (Wolf-Parkinson-White Syndrome) 08/2008
1	Optic Atrophy 08/2008
1	Cardiomyopathies (Cardiomyopathy) 08/2008
1	Leigh Disease (Leigh's Disease) 08/2008

Drug/Important Bio-Agent (IBA)

3	Pharmaceutical PreparationsIBA 01/2020 - 01/2019
2	AntibodiesIBA 01/2020 - 07/2019
2	Antineoplastic Agents (Antineoplastics)IBA 01/2020 - 09/2012
2	AntigensIBA 07/2019 - 09/2018
2	Proteins (Proteins, Gene)FDA Link 12/2018 - 01/2018
2	H-cadherin (T-cadherin)IBA 09/2017 - 02/2015
1	Neutralizing AntibodiesIBA 12/2020
1	Hematoxylin (Haematoxylon)IBA 08/2020
1	Eosine Yellowish-(YS) (Eosin)IBA 08/2020
1	CTLA-4 AntigenIBA 01/2020
1	B7-H1 AntigenIBA 01/2020
1	Immune Checkpoint InhibitorsIBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 12/2019
1	Bevacizumab (Avastin)FDA Link 10/2019
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 10/2019
1	CarbohydratesIBA 07/2019
1	Cancer VaccinesIBA 07/2019
1	CeramidesIBA 01/2019
1	graphene oxideIBA 01/2019
1	poly(ethylene glycol)-co-poly(ethyleneimine)IBA 01/2019
1	talimogene laherparepvecIBA 01/2019
1	Therapeutic UsesIBA 01/2019
1	Sorafenib (BAY 43-9006)FDA Link 01/2019
1	N-caproylsphingosineIBA 01/2019
1	Messenger RNA (mRNA)IBA 12/2018
1	Leucine (L-Leucine)FDA Link 12/2018
1	NucleotidesIBA 12/2018
1	Fetal Proteins (Fetoprotein)IBA 09/2018
1	Imatinib Mesylate (Gleevec)FDA Link 01/2018
1	ovatodiolideIBA 01/2018
1	QuercetinIBA 01/2018
1	adenovirus receptorIBA 09/2016
1	Substance PIBA 01/2016
1	Neurokinin-1 Receptors (Neurokinin 1 Receptor)IBA 01/2016
1	Immunologic Factors (Immunomodulators)IBA 01/2016
1	TachykininsIBA 01/2016
1	CaspasesIBA 09/2012
1	Amino Acids FDA Link 09/2012
1	LigandsIBA 09/2012
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2012
1	BromidesIBA 02/2012
1	bisbenzimide ethoxide trihydrochloride (Hoechst 33342)IBA 02/2012
1	dl1520 (ONYX-015)IBA 02/2012
1	alpha-Fetoproteins (alpha-Fetoprotein)IBA 02/2012
1	DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA 02/2012
1	Mitochondrial DNA (mtDNA)IBA 08/2008
1	Carnitine (L-Carnitine)FDA LinkGeneric 08/2008
1	Levetiracetam (Keppra)FDA LinkGeneric 08/2008
1	coenzyme Q10 (CoQ10)IBA 08/2008
1	Thiamine (Aneurin)FDA Link 08/2008

Therapy/Procedure

8	Therapeutics 02/2021 - 02/2012
2	Immunotherapy 10/2020 - 07/2019
2	Precision Medicine 01/2020 - 01/2017
2	Drug Therapy (Chemotherapy) 01/2020 - 01/2018
1	Neoadjuvant Therapy 08/2020
1	Oncolytic Virotherapy 06/2020
1	Phototherapy (Light Therapy) 01/2020